Persistence of the Metabolic Syndrome Over 3 Annual Visits in Overweight Hispanic Children: Association with Progressive Risk for Type 2 Diabetes


      To examine an association between persistent metabolic syndrome (MetS) and the risk for type 2 diabetes in overweight Hispanic children.

      Study design

      A total of 73 subjects (mean age, 11.0 ± 1.7 years) from a longitudinal study were classified as Never (negative for MetS at all 3 annual visits), Intermittent (positive for MetS at 1 or 2 visits), or Persistent (positive for MetS at all 3 visits). Measures included dual-energy x-ray absorptiometry, magnetic resonance imaging, the 2-hour oral glucose tolerance test, and the frequently sampled intravenous glucose tolerance test.


      The Persistent group had a faster rate of fat mass gain than the Never group (20% vs 15% gain of baseline value; P < .05 for time∗group interaction [time = visit]). Independent of body composition, the Persistent group increased by 70% in insulin incremental area under the curve, whereas the other groups decreased (P < .05 for time∗group interaction). Despite no time∗group interactions for insulin sensitivity, acute insulin response, or disposition index, the Persistent group maintained 43% lower insulin sensitivity (P < .01) and by visit 2 had a 25% lower disposition index (P < .05) compared with the Never group.


      Patients with persistent MetS had accelerated fat gain, increased insulin response to oral glucose, and decreased sensitivity and beta cell function, indicators of progressively greater risk for type 2 diabetes
      AIR (Acute insulin response to glucose), ANCOVA (Analysis of covariance), ANOVA (Analysis of variance), AUC (Area under the curve), BMI (Body mass index), DEXA (Dual-energy x-ray absorptiometry), DI (Disposition index), FSIVGTT (Frequently sampled intravenous glucose tolerance test), HDL (High-density lipoprotein), IAAT (Intra-abdominal adipose tissue), IAUC (Incremental area under the curve), MetS (Metabolic syndrome), MRI (Magnetic resonance imaging), OGGT (Oral glucose tolerance test), SAAT (Subcutaneous abdominal adipose tissue), SI (Insulin sensitivity), SOLAR (Study of Latino Adolescents at Risk for Diabetes)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lee J.M.
        • Okumura M.J.
        • Davis M.M.
        • Herman W.H.
        • Gurney J.G.
        Prevalence and determinants of insulin resistance among US adolescents: a population-based study.
        Diabetes Care. 2006; 29: 2427-2432
        • Cruz M.L.
        • Bergman R.N.
        • Goran M.I.
        Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes.
        Diabetes Care. 2002; 25: 1631-1636
        • Goran M.I.
        • Bergman R.N.
        • Gower B.A.
        Influence of total versus visceral fat on insulin action and secretion in African-American and white children.
        Obes Res. 2001; 9: 423-431
        • Goran M.I.
        • Ball G.D.
        • Cruz M.L.
        Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.
        J Clin Endocrinol Metab. 2003; 88: 1417-1427
        • Goran M.I.
        • Bergman R.N.
        • Cruz M.L.
        • Watanabe R.
        Insulin resistance and associated compensatory responses in African-American and Hispanic children.
        Diabetes Care. 2002; 25: 2184-2190
        • Grundy S.M.
        A constellation of complications: the metabolic syndrome.
        Clin Cornerstone. 2005; 7: 36-45
        • Cook S.
        • Weitzman M.
        • Auinger P.
        • Nguyen M.
        • Dietz W.H.
        Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.
        Arch Pediatr Adolesc Med. 2003; 157: 821-827
        • Cruz M.L.
        • Weigensberg M.J.
        • Huang T.T.
        • Ball G.
        • Shaibi G.Q.
        • Goran M.I.
        The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
        J Clin Endocrinol Metab. 2004; 89: 108-113
        • National Center for Health Statistics
        CDC Growth Charts: United States.
        US Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD2000
        • American Diabetes Association
        Clinical practice recommendations, 2002.
        Diabetes Care. 2002; 25: S1-S147
        • Goran M.I.
        • Bergman R.N.
        • Avila Q.
        • Watkins M.
        • Ball G.D.
        • Shaibi G.Q.
        • et al.
        Impaired glucose tolerance and reduced beta-cell function in overweight Hispanic children with a positive family history for type 2 diabetes.
        J Clin Endocrinol Metab. 2004; 89: 207-212
        • Weigensberg M.J.
        • Ball G.D.
        • Shaibi G.Q.
        • Cruz M.L.
        • Goran M.I.
        Decreased beta-cell function in overweight Hispanic children with impaired fasting glucose.
        Diabetes Care. 2005; 28: 2519-2524
        • National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents
        The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.
        Pediatrics. 2004; 114: 555-576
        • Tanner J.M.
        Growth and maturation during adolescence.
        Nutr Rev. 1981; 39: 43-55
        • Shaibi G.Q.
        • Goran M.I.
        Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance.
        J Pediatr. 2008; 152: 171-176
        • Jones K.L.
        The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?.
        Pediatr Diabetes. 2006; 7: 311-321
        • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)
        Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Fernandez J.R.
        • Redden D.T.
        • Pietrobelli A.
        • Allison D.B.
        Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents.
        J Pediatr. 2004; 145: 439-444
        • Hickman T.B.
        • Briefel R.R.
        • Carroll M.D.
        • Rifkind B.M.
        • Cleeman J.I.
        • Maurer K.R.
        • et al.
        Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.
        Prev Med. 1998; 27: 879-890
        • Goodman E.
        • Daniels S.R.
        • Meigs J.B.
        • Dolan L.M.
        Instability in the diagnosis of metabolic syndrome in adolescents.
        Circulation. 2007; 115: 2316-2322
        • Weiss R.
        • Dziura J.
        • Burgert T.S.
        • Tamborlane W.V.
        • Taksali S.E.
        • Yeckel C.W.
        • et al.
        Obesity and the metabolic syndrome in children and adolescents.
        N Engl J Med. 2004; 350: 2362-2374
        • Ventura A.K.
        • Loken E.
        • Birch L.L.
        Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls.
        Pediatrics. 2006; 118: 2434-2442
        • Franks P.W.
        • Hanson R.L.
        • Knowler W.C.
        • Moffett C.
        • Enos G.
        • Infante A.M.
        • et al.
        Childhood predictors of young-onset type 2 diabetes.
        Diabetes. 2007; 56: 2964-2972
        • Morrison J.A.
        • Friedman L.A.
        • Wang P.
        • Glueck C.J.
        Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later.
        J Pediatr. 2008; 152: 201-206
        • Weyer C.
        • Tataranni P.A.
        • Bogardus C.
        • Pratley R.E.
        Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
        Diabetes Care. 2001; 24: 89-94
      1. Haffner SM, Miettinen H, S.P. G, M.P. S. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995;44:1386–91.

        • Buchanan T.A.
        (How) can we prevent type 2 diabetes?.
        Diabetes. 2007; 56: 1502-1507
        • Goran M.I.
        • Coronges K.
        • Bergman R.N.
        • Cruz M.L.
        • Gower B.A.
        Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children.
        J Clin Endocrinol Metab. 2003; 88: 192-195
        • American Diabetes Association
        Type 2 diabetes in children and adolescents.
        Diabetes Care. 2000; 23: 381-389

      Linked Article